Cargando…
IMT504 protects beta cells against apoptosis and maintains beta cell identity, without modifying proliferation
We have demonstrated that oligodeoxynucleotide IMT504 promotes significant improvement in the diabetic condition in diverse animal models. Based on these results, here we evaluated whether these effects observed in vivo could be due to direct effects on β‐cells. We demonstrate by immunofluorescence...
Autores principales: | Converti, Ayelén, Bianchi, María Silvia, Martinez, Mario D., Montaner, Alejandro D., Lux‐Lantos, Victoria, Bonaventura, María Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421975/ https://www.ncbi.nlm.nih.gov/pubmed/37568265 http://dx.doi.org/10.14814/phy2.15790 |
Ejemplares similares
-
SAT-165 Does Oligodeoxynucleotide IMT504 Have Any Effect On Beta Cells? A Preliminary Study On MIN6B1 Cell Line
por: Converti, Ayelén, et al.
Publicado: (2019) -
SAT-172 Continuous, Prolonged Treatment with the Oligonucleotide IMT504 in Diabetic NOD Mice Greatly Improves All Parameters of the Diabetic Condition
por: Bianchi, Stefania, et al.
Publicado: (2019) -
SAT035 Oligonucleotide IMT504 Markedly Improves Metabolic Sindrome And Type 2 Diabetes In High-Fat Diet Fed Mice
por: Domé, Laila, et al.
Publicado: (2023) -
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy
por: Zorzopulos, Jorge, et al.
Publicado: (2017) -
XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice
por: Lee, Kailun, et al.
Publicado: (2022)